NDC 51759-312 - Adalimumab-ryvk

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 51759-312
Package NDCs from labels: 51759-312-30
Manufacturer: Teva Pharmaceuticals USA, Inc.
Effective date: 2026-03-03
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Adalimumab-ryvk - Teva Pharmaceuticals USA, Inc.	Teva Pharmaceuticals USA, Inc.	2026-03-03	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51759-312-30	Adalimumab-ryvk	0.4 mL in 1 SYRINGE	INJECTION, SOLUTION	0.4 mL	40 mg in 0.4mL	1